Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
40%
Ph phase_3
1
20%
Ph not_applicable
1
20%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(1)
Other(1)

Detailed Status

Recruiting2
Completed1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (50.0%)
Phase 31 (25.0%)
N/A1 (25.0%)

Trials by Status

recruiting240%
completed120%
not_yet_recruiting120%
unknown120%

Recent Activity

2 active trials
Showing 5 of 5
recruitingphase_1

Clinical Study of the Safety and Efficacy of QH101 Cell in Patients With Malignant Tumors.

NCT07570563
recruitingphase_1

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

NCT05702853
not_yet_recruitingphase_3

Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR

NCT06297772
completed

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

NCT03609814
unknownnot_applicable

a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients

NCT04008888

Clinical Trials (5)

Showing 5 of 5 trials
NCT07570563Phase 1

Clinical Study of the Safety and Efficacy of QH101 Cell in Patients With Malignant Tumors.

Recruiting
NCT05702853Phase 1

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

Recruiting
NCT06297772Phase 3

Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR

Not Yet Recruiting
NCT03609814

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

Completed
NCT04008888Not Applicable

a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5